Sarepta Therapeutics Receives Rare Pediatric Disease Designation From FDA
August 21, 2015 at 12:03 PM EDT
Sarepta receives rare pediatric disease designation from FDA for Eteplirsen to tread duchenne muscular dystrophy.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |